查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040510

食慾促效劑市場規模、佔有率和趨勢分析報告：按藥理分類、適應症、給藥途徑、分銷管道、地區和細分市場預測（2026-2033 年）

Appetite Stimulant Market Size, Share & Trends Analysis Report By Pharmacological Class, By Indication, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

食慾促效劑市場概述

據估計，2025年全球食慾促效劑市值為17.3億美元，預計2033年將達到29億美元。

預計從 2026 年到 2033 年，該市場將以 6.76% 的複合年成長率成長。該市場旨在滿足食慾不振和非自願性體重減輕患者的未滿足需求。

該市場在改善患者預後方面發揮著至關重要的作用，尤其是在疾病管理和復原方面。人們對生活品質和支持性照護日益成長的關注，進一步提升了整個醫療保健系統中食慾增強解決方案的重要性。不斷上漲的醫療成本和對綜合患者護理日益重視，也推動了該市場的成長。

受癌症、愛滋病和神經性厭食症等慢性疾病日益普遍的影響，食慾促效劑市場正穩定成長。這些疾病容易導致非預期體重下降和營養不良。人們對臨床營養和支持性護理的認知不斷提高，促使醫療專業人員將食慾促效劑納入綜合治療方案。雖然皮質類固醇、大麻素和黃體素等藥物被廣泛使用，但天然和草藥替代品正受到尋求更安全、長期解決方案的患者的青睞。老年人口不斷成長，由於與老齡化相關的生理變化，更容易出現食慾不振，這進一步推動了市場需求。醫院和長期照護機構也是重要的終端用戶，支撐著穩定的消費。在醫療基礎設施改善和治療機會增加的推動下，新興市場對食慾促效劑的需求也不斷成長。

此外，為了提高患者的依從性和療效，該行業正透過藥物配方和給藥機制的創新不斷發展。各公司正加大研發投入，開發副作用較少的標靶治療，以解決傳統食慾促效劑的相關問題。人們對醫用大麻，特別是含有屈大麻酚的產品的興趣日益濃厚，這為食慾刺激開闢了新的途徑，尤其是在腫瘤科和安寧療護領域。監管核准和臨床試驗持續影響競爭格局，並左右各地區的產品供應。同時，營養保健品產業也在快速擴張，其補充劑旨在透過維生素和草藥萃取物自然地刺激食慾。與數位醫療和機能性食品營養方法的融合也正在蓬勃發展，從而能夠為每位患者量身定做治療方案。總體而言，在疾病負擔日益加重和治療方法不斷進步的推動下，食慾促效劑行業預計將保持中等至強勁的成長動能。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：食慾促效劑市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 商業環境分析

第4章 食慾促效劑市場：基於藥理分類的商業分析

  • 按藥理學分類分類的市場佔有率（2025 年和 2033 年）
  • 按藥理分類分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 孕酮製劑及荷爾蒙製劑
  • 大麻素和中樞神經促效劑
  • 促進吸收和新陳代謝的藥物
  • 營養補充品/微量營養素補充劑
  • 其他

第5章：食慾促效劑市場：依適應症分類的業務分析

  • 按適應症分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測與趨勢分析：按適應症分類，2021-2033 年
  • 疾病相關性惡病質
  • 與慢性疾病相關的營養不良
  • 與老齡化的厭食症和一般性厭食症
  • 兒童營養不良
  • 其他

第6章：食慾促效劑市場：依給藥途徑進行業務分析

  • 按行政途徑分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測與趨勢分析：按給藥途徑分類，2021-2033 年
  • 口服
  • 腸外（注射用）

第7章：食慾促效劑市場：按分銷管道分類的業務分析

  • 按分銷管道分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測與趨勢分析：按分銷管道分類，2021-2033 年
  • 醫院藥房
  • 零售藥房
  • 其他

第8章：食慾促效劑市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 參與企業概況
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介列表
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Johnson & Johnson
    • GlaxoSmithKline plc（GSK）.
    • Novartis AG
    • Sanofi SA
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
Product Code: GVR-4-68040-894-5

Appetite Stimulant Market Summary

The global appetite stimulant market size was estimated at USD 1.73 billion in 2025 and is projected to reach USD 2.90 billion by 2033, growing at a CAGR of 6.76% from 2026 to 2033. The market addresses unmet needs in patients experiencing reduced appetite and unintended weight loss.

It plays a critical role in improving patient outcomes, particularly in disease management and recovery phases. Growing emphasis on quality of life and supportive therapies has increased the relevance of appetite-enhancing solutions across healthcare systems. The market also benefits from rising healthcare expenditure and a greater focus on holistic patient care.

The appetite stimulant market is experiencing steady growth, driven by the rising prevalence of chronic conditions such as Cancer, HIV/AIDS, and Anorexia Nervosa that often lead to unintended weight loss and malnutrition. Increasing awareness of clinical nutrition and supportive care has encouraged healthcare providers to incorporate appetite stimulants into comprehensive treatment plans. Pharmaceutical options, including corticosteroids, cannabinoids, and progestogens, are widely prescribed, while natural and herbal alternatives are gaining traction among patients seeking safer long-term solutions. The expanding geriatric population, which is more susceptible to appetite loss due to age-related physiological changes, further supports market demand. Additionally, hospital settings and long-term care facilities are key end users contributing to consistent consumption. Emerging markets are also witnessing increased adoption driven by improving healthcare infrastructure and greater access to treatment.

Furthermore, the industry is evolving through innovations in drug formulations and delivery mechanisms to improve patient compliance and efficacy. Companies are investing in research to develop targeted therapies with fewer side effects, addressing concerns associated with traditional appetite stimulants. The growing interest in medical cannabis, particularly products containing Dronabinol, has opened new avenues for appetite stimulation, especially in oncology and palliative care. Regulatory approvals and clinical trials continue to shape the competitive landscape, influencing product availability across regions. In parallel, the nutraceutical segment is expanding rapidly, with supplements designed to enhance appetite naturally through vitamins and herbal extracts. Digital health integration and personalized nutrition approaches are also gaining momentum, enabling tailored treatment strategies. Overall, the appetite stimulant industry is positioned for moderate to strong growth, supported by rising disease burden and ongoing therapeutic advancements.

Global Appetite Stimulant Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global appetite stimulant market report based on pharmacological class, indication, route of administration, distribution channel, and region:

  • Pharmacological class Outlook (Revenue, USD Billion, 2021 - 2033)
  • Progestational & Hormonal Agents
  • Cannabinoids & CNS-Acting Agents
  • Anabolic & Metabolic Agents
  • Nutritional / Micronutrient Agents
  • Others
  • Indication Outlook (Revenue, USD Billion, 2021 - 2033)
  • Disease-Related Cachexia
  • Chronic Disease-Associated Malnutrition
  • Age-Related & General Anorexia
  • Pediatric Undernutrition
  • Others
  • Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)
  • Oral
  • Parenteral (Injectable)
  • Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Pharmacological class
    • 1.2.2. Indication
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Appetite Stimulant Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Appetite Stimulant Market: Pharmacological class Business Analysis

  • 4.1. Pharmacological class Market Share, 2025 & 2033
  • 4.2. Pharmacological class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Pharmacological class, 2021 to 2033 (USD Billion)
  • 4.4. Progestational & Hormonal Agents
    • 4.4.1. Progestational & Hormonal Agents Market, 2021 - 2033 (USD Billion)
  • 4.5. Cannabinoids & CNS-Acting Agents
    • 4.5.1. Cannabinoids & CNS-Acting Agents Market, 2021 - 2033 (USD Billion)
  • 4.6. Anabolic & Metabolic Agents
    • 4.6.1. Anabolic & Metabolic Agents Market, 2021 - 2033 (USD Billion)
  • 4.7. Nutritional / Micronutrient Agents
    • 4.7.1. Nutritional / Micronutrient Agents Market, 2021 - 2033 (USD Billion)
  • 4.8. Others
    • 4.8.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 5. Appetite Stimulant Market: Indication Business Analysis

  • 5.1. Indication Market Share, 2025 & 2033
  • 5.2. Indication Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Indication, 2021 to 2033 (USD Billion)
  • 5.4. Disease-Related Cachexia
    • 5.4.1. Disease-Related Cachexia Market, 2021 - 2033 (USD Billion)
  • 5.5. Chronic Disease-Associated Malnutrition
    • 5.5.1. Chronic Disease-Associated Malnutrition Market, 2021 - 2033 (USD Billion)
  • 5.6. Age-Related & General Anorexia
    • 5.6.1. Age-Related & General Anorexia Market, 2021 - 2033 (USD Billion)
  • 5.7. Pediatric Undernutrition
    • 5.7.1. Pediatric Undernutrition Market, 2021 - 2033 (USD Billion)
  • 5.8. Others
    • 5.8.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 6. Appetite Stimulant Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2025 & 2033
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Billion)
  • 6.4. Oral
    • 6.4.1. Oral Market, 2021 - 2033 (USD Billion)
  • 6.5. Parenteral (Injectable)
    • 6.5.1. Parenteral (Injectable) Market, 2021 - 2033 (USD Billion)

Chapter 7. Appetite Stimulant Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2025 & 2033
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution channel, 2021 to 2033 (USD Billion)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
  • 7.5. Retail Pharmacies
    • 7.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion)
  • 7.6. Others
    • 7.6.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 8. Appetite Stimulant Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 8.4. North America
    • 8.4.1. North America Appetite Stimulant Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Billion)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Framework
      • 8.4.2.5. U.S. Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Framework
      • 8.4.3.5. Canada Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Framework
      • 8.4.4.5. Mexico Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5. Europe
    • 8.5.1. Europe Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Framework
      • 8.5.2.5. UK Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Framework
      • 8.5.3.5. Germany Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement Framework
      • 8.5.4.5. France Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement Framework
      • 8.5.5.5. Italy Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Target Disease Prevalence
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement Framework
      • 8.5.6.5. Spain Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Target Disease Prevalence
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement Framework
      • 8.5.7.5. Denmark Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Target Disease Prevalence
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement Framework
      • 8.5.8.5. Sweden Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Target Disease Prevalence
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement Framework
      • 8.5.9.5. Norway Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Framework
      • 8.6.2.5. Japan Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Framework
      • 8.6.3.5. China Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Framework
      • 8.6.4.5. India Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Framework
      • 8.6.5.5. Australia Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement Framework
      • 8.6.6.5. South Korea Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Target Disease Prevalence
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement Framework
      • 8.6.7.5. Thailand Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7. Latin America
    • 8.7.1. Latin America Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Target Disease Prevalence
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement Framework
      • 8.7.2.5. Brazil Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Target Disease Prevalence
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement Framework
      • 8.7.3.5. Argentina Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Target Disease Prevalence
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement Framework
      • 8.8.2.5. South Africa Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Target Disease Prevalence
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement Framework
      • 8.8.3.5. Saudi Arabia Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Target Disease Prevalence
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement Framework
      • 8.8.4.5. UAE Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Target Disease Prevalence
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement Framework
      • 8.8.5.5. Kuwait Appetite Stimulant Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Pfizer Inc.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Merck & Co., Inc.
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Johnson & Johnson
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. GlaxoSmithKline plc (GSK).
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Novartis AG
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Sanofi S.A.
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. AbbVie Inc.
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Teva Pharmaceutical Industries Ltd.
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global appetite stimulant market, by region, 2021 - 2033 (USD Billion)
  • Table 4 Global appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 5 Global appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 6 Global appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 7 Global appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 8 North America appetite stimulant market, by country, 2021 - 2033 (USD Billion)
  • Table 9 North America appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 10 North America appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 11 North America appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 12 North America appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 13 U.S appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 14 U.S appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 15 U.S appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 16 U.S appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 17 Canada appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 18 Canada appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 19 Canada appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 20 Canada appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 21 Mexico appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 22 Mexico appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 23 Mexico appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 24 Mexico appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 25 Europe appetite stimulant market, by country, 2021 - 2033 (USD Billion)
  • Table 26 Europe appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 27 Europe appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 28 Europe appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 29 Europe appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 30 UK appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 31 UK appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 32 UK appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 33 UK appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 34 Germany appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 35 Germany appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 36 Germany appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 37 Germany appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 38 France appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 39 France appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 40 France appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 41 France appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 42 Italy appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 43 Italy appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 44 Italy appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 45 Italy appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 46 Spain appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 47 Spain appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 48 Spain appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 49 Spain appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 50 Norway appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 51 Norway appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 52 Norway appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 53 Norway appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 54 Denmark appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 55 Denmark appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 56 Denmark appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 57 Denmark appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 58 Sweden appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 59 Sweden appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 60 Sweden appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 61 Sweden appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 62 Asia Pacific appetite stimulant market, by country, 2021 - 2033 (USD Billion)
  • Table 63 Asia Pacific appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 64 Asia Pacific appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 65 Asia Pacific appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 66 Asia Pacific appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 67 Japan appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 68 Japan appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 69 Japan appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 70 Japan appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 71 China appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 72 China appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 73 China appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 74 China appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 75 India appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 76 India appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 77 India appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 78 India appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 79 Australia appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 80 Australia appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 81 Australia appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 82 Australia appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 83 South Korea appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 84 South Korea appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 85 South Korea appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 86 South Korea appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 87 Thailand appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 88 Thailand appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 89 Thailand appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 90 Thailand appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 91 Latin America appetite stimulant market, by country, 2021 - 2033 (USD Billion)
  • Table 92 Latin America appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 93 Latin America appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 94 Latin America appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 95 Latin America appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 96 Brazil appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 97 Brazil appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 98 Brazil appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 99 Brazil appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 100 Argentina appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 101 Argentina appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 102 Argentina appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 103 Argentina appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 104 Middle East & Africa appetite stimulant market, by country, 2021 - 2033 (USD Billion)
  • Table 105 Middle East & Africa appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 106 Middle East & Africa appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 107 Middle East & Africa appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 108 Middle East appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 109 South Africa appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 110 South Africa appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 111 South Africa appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 112 South Africa appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 113 Saudi Arabia appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 114 Saudi Arabia appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 115 Saudi Arabia appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 116 Saudi Arabia appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 117 UAE appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 118 UAE appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 119 UAE appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 120 UAE appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 121 Kuwait appetite stimulant market, by pharmacological class, 2021 - 2033 (USD Billion)
  • Table 122 Kuwait appetite stimulant market, by indication, 2021 - 2033 (USD Billion)
  • Table 123 Kuwait appetite stimulant market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 124 Kuwait appetite stimulant market, by route of administration, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Appetite stimulant market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 Appetite stimulant market dynamics
  • Fig. 11 Appetite stimulant market: Porter's five forces analysis
  • Fig. 12 Appetite stimulant market: PESTLE analysis
  • Fig. 13 Pharmacological class market, 2021 - 2033 (USD Billion)
  • Fig. 14 Progestational & Hormonal Agents market, 2021 - 2033 (USD Billion)
  • Fig. 15 Cannabinoids & CNS-Acting Agents market, 2021 - 2033 (USD Billion)
  • Fig. 16 Anabolic & Metabolic Agents market, 2021 - 2033 (USD Billion)
  • Fig. 17 Nutritional / Micronutrient Agents market, 2021 - 2033 (USD Billion)
  • Fig. 18 Others market, 2021 - 2033 (USD Billion)
  • Fig. 19 Indication market, 2021 - 2033 (USD Billion)
  • Fig. 20 Disease-Related Cachexia market, 2021 - 2033 (USD Billion)
  • Fig. 21 Chronic Disease-Associated Malnutrition market, 2021 - 2033 (USD Billion)
  • Fig. 22 Age-Related & General Anorexia market, 2021 - 2033 (USD Billion)
  • Fig. 23 Pediatric Undernutrition market, 2021 - 2033 (USD Billion)
  • Fig. 24 Others market, 2021 - 2033 (USD Billion)
  • Fig. 25 Route of Administration market, 2021 - 2033 (USD Billion)
  • Fig. 26 Oral market, 2021 - 2033 (USD Billion)
  • Fig. 27 Parenteral (Injectable) market, 2021 - 2033 (USD Billion)
  • Fig. 28 Distribution channel market, 2021 - 2033 (USD Billion)
  • Fig. 29 Hospital pharmacies market, 2021 - 2033 (USD Billion)
  • Fig. 30 Retail Pharmacies market, 2021 - 2033 (USD Billion)
  • Fig. 31 Others market, 2021 - 2033 (USD Billion)
  • Fig. 32 Appetite stimulant market revenue, by region
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 35 U.S. country dynamics
  • Fig. 36 U.S. Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 37 Canada country dynamics
  • Fig. 38 Canada Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 39 Mexico country dynamics
  • Fig. 40 Mexico Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 41 Europe Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 42 UK country dynamics
  • Fig. 43 UK Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 44 Germany country dynamics
  • Fig. 45 Germany Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 46 France country dynamics
  • Fig. 47 France Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 48 Italy country dynamics
  • Fig. 49 Italy Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 50 Spain country dynamics
  • Fig. 51 Spain Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 52 Norway country dynamics
  • Fig. 53 Norway Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 54 Sweden country dynamics
  • Fig. 55 Sweden Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 56 Denmark country dynamics
  • Fig. 57 Denmark Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 58 Asia Pacific Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 59 Japan country dynamics
  • Fig. 60 Japan Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 61 China country dynamics
  • Fig. 62 China Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 63 India country dynamics
  • Fig. 64 India Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 65 Australia country dynamics
  • Fig. 66 Australia Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 67 South Korea country dynamics
  • Fig. 68 South Korea Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 69 Thailand country dynamics
  • Fig. 70 Thailand Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 71 Latin America Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 72 Brazil country dynamics
  • Fig. 73 Brazil Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 74 Argentina country dynamics
  • Fig. 75 Argentina Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 76 MEA Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 77 South Africa country dynamics
  • Fig. 78 South Africa Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 79 Saudi Arabia country dynamics
  • Fig. 80 Saudi Arabia Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 81 UAE country dynamics
  • Fig. 82 UAE Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 83 Kuwait country dynamics
  • Fig. 84 Kuwait Appetite stimulant market, 2021 - 2033 (USD Billion)
  • Fig. 85 Company categorization
  • Fig. 86 Company market position analysis
  • Fig. 87 Strategic framework